Non-small cell lung cancer

• Study to allow access to dabrafenib and/or trametinib for subjects that are benefiting from dabrafenib and/or trametinib treatment in a Nova … Recruiting
  2023-509318-13-00 6 2018-01-15 "Multiple indications"
• Study of zoldonrasib in Previously Treated Patients with RAS G12D-Mutant Non-Small Cell Lung Cancer (NSCLC) Recruitment ended
  2025-521681-10-00 4 2025-10-02 "Lung Cancer"
• A Phase I/IIa Study of Roginolisib in combination with dostarlimab with or without docetaxel in Advanced NSCLC (PULMO-01) Recruitment ended
  2024-517741-14-00 9 2025-04-22 "advanced non-squamous non-small cell lung cancer (NSCLC)"
• A study to learn if a combination of Fianlimab and Cemiplimab versus Cemiplimab alone is more effective for adult participants with Advanced … Recruitment ended
  2022-501483-18-00 10 2025-03-28 "Advanced Non-Small Cell Lung Cancer"
• AMG 193 Alone or in Combination With Other Therapies in Subjects With Advanced Thoracic Tumors With Homozygous MTAP-deletion (Master Protoco … Recruitment ended
  2024-511253-21-00 3 2025-02-28 "Thoracic tumors with homozygous MTAP-deletion"
• Study of EGF816 in combination with selected targeted agents in EGFR-mutant NSCLC. Recruitment ended
  2024-511757-21-00 3 2024-12-20 "Patients with EGFR-mutant Non Small Cell Lung Cancer"
• Study of safety and efficacy of DKY709 alone or in combination with PDR001 in patients with advanced solid tumors. Recruitment ended
  2024-513281-19-00 1 2024-11-25 "Nasopharyngeal Carcinoma"
• Study of SKB264 to treat participants with advanced non-small cell lung cancer alone or as a combination treatment Recruitment ended
  2023-507270-41-00 4 2024-11-22 "Advanced or Metastatic Non-small Cell Lung Cancer"
• Study of JDQ443 in advanced cancer with a specific mutation (G12C) of the KRAS gene Recruitment ended
  2023-508073-87-00 7 2024-11-14 "Advance solid tumors harboring the KRAS G12C mutation"
• A Phase 2 Trial of Combination Therapies with Adagrasib in Patients with Advanced Non-Small Cell Lung Cancer with KRAS G12C Mutation Recruitment ended
  2023-503714-77-00 4 2024-10-01 "Advanced Non-Small Cell Lung Cancer"
• A Study Evaluating the Efficacy and Safety of Divarasib Versus Sotorasib or Adagrasib in Patients with previously treated KRAS G12C-positive … Recruitment ended
  2024-510908-37-00 5 2024-08-28 "KRAS G12C-Positive Advanced or Metastatic Non-Small Cell Lun"
• A Clinical Study to Evaluate the Safety and Efficacy of Amivantamab and Capmatinib Combination Therapy in Unresectable Metastatic Non-small … Recruitment ended
  2023-508256-19-00 9 2024-07-15 "Unresectable Metastatic Non-small Cell Lung Cancer"
• A multicentre, Phase II, single-arm, interventional study of neoadjuvant durvalumab and platinum-based chemotherapy (CT), followed by either … Recruitment ended
  2023-503357-35-00 4 2024-03-20 "Non-small Cell Lung Cancer (NSCLC)"
• A phase I, open-label, multi-center study of KFA115 as a single agent and in combination with pembrolizumab in patients with select advanced … Recruitment ended
  2022-502381-25-01 1 2024-03-15 "Thymic Carcinoma"
• A study of sigvotatug vedotin versus docetaxel in previously treated non-small cell lung cancer (Be6A Lung-01) Recruitment ended
  2023-503827-25-01 5 2024-02-16 "Non-Small Cell Lung Cancer (NSCLC)"
• Patient Preference Study of SC Pembrolizumab versus IV Pembrolizumab with hyaluronidase (MK-3475A) in multiple cancer types Recruitment ended
  2023-506017-22-00 4 2024-02-16 "Melanoma, Renal Cell Carcinoma, Non-small cell lung cancer"
• A study of zipalertinib and chemotherapy compared with chemotherapy alone in patients with advanced Non-Small Cell Lung Cancer with Epiderma … Recruitment ended
  2023-503575-21-00 5 2024-01-23 "Non-Small Cell Lung Cancer Harboring EGFR Exon 20 Insertion "
• ETOP 14-18 CHESS: Immunotherapy, chemotherapy and radiotherapy, followed by surgery or radiotherapy, for patients with newly diagnosed non-s … Recruitment ended
  2024-511134-12-00 4 2023-12-20 "NSCLC, synchronous oligo-metastatic"
• Phase 1/2 Study of Avutometinib (VS-6766) + Sotorasib in G12C NSCLC Patients (RAMP203) Recruitment ended
  2023-505107-24-00 9 2023-11-14
• A Phase 3 Study of Front‑line Platinum Doublet Therapy With Sotorasib Versus Pembrolizumab in PD-L1 Negative KRAS p.G12C Positive Advanced/M … Recruitment ended
  2022-501863-41-00 5 2023-11-13 "Subjects With Stage IV or Advanced Stage IIIB/C Nonsquamous "
• A Randomized Phase 3 Study of Datopotamab Deruxtecan (Dato-DXd) and Pembrolizumab, with or Without Platinum Chemotherapy, in Subjects with N … Recruitment ended
  2022-500802-16-00 5 2023-11-01 "Advanced or Metastatic PD-L1 TPS <50% Non-squamous Non-small"
• Phase I study of AZD9592 in solid tumors Recruitment ended
  2022-501570-18-00 1 2023-07-18 "Recurrent or metastatic Head and NeckSquamous Cell Carcinoma"
• Study of chemotherapy and immunotherapy before and after surgery in patients with non-small cell lung cancer whose tumor is located in the u … Recruitment ended
  2024-512359-19-00 4 2023-05-12 "Resectable Non-small cell lung cancer Pancoast tumor"
• ETOP 22-22 ADEPPT: A study of adagrasib for patients with KRASG12C-mutant non-small cell lung cancer (NSCLC), who are elderly or who are unw … Recruitment ended
  2023-510463-35-00 4 2023-04-26 "Patients with KRASG12C-mutant NSCLC, including patients aged"

Showing 97–120 of 234 trials